Cargando…
A Network-Based Gene Expression Signature Informs Prognosis and Treatment for Colorectal Cancer Patients
BACKGROUND: Several studies have reported gene expression signatures that predict recurrence risk in stage II and III colorectal cancer (CRC) patients with minimal gene membership overlap and undefined biological relevance. The goal of this study was to investigate biological themes underlying these...
Autores principales: | Shi, Mingguang, Beauchamp, R. Daniel, Zhang, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402487/ https://www.ncbi.nlm.nih.gov/pubmed/22844451 http://dx.doi.org/10.1371/journal.pone.0041292 |
Ejemplares similares
-
ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients
por: Shi, Mingguang, et al.
Publicado: (2016) -
CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer
por: Nguyen, Minh Nam, et al.
Publicado: (2015) -
Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients
por: Li, Jianxia, et al.
Publicado: (2020) -
Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia
por: Shi, Mingguang, et al.
Publicado: (2019) -
Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review
por: Sanz-Pamplona, Rebeca, et al.
Publicado: (2012)